Evidence map›Paper›PMID 29784775›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Recombinant

Yoojin Choi, Tae Jung Park, Doh C Lee, Sang Yup Lee

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. EngineeringACS synthetic biology · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. The Pd (II) Reduction Mechanisms inNanomaterials (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Review
  12. Cloneable inorganic nanoparticles.Chemical communications (Cambridge, England) · 2023
    Review
  13. Applications of synthetic biology in medical and pharmaceutical fields.Signal transduction and targeted therapy · 2023
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Yoojin ChoiMetabolic and Biomolecular Engineering National Research Laboratory, Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141 Daejeon, Republic of Korea.
Tae Jung ParkDepartment of Chemistry, Research Institute for Halal Industrialization Technology, Chung-Ang University, Dongjak-gu, 06974 Seoul, Republic of Korea leesy@kaist.ac.kr tjpark@cau.ac.kr.
Doh C LeeDepartment of Chemical and Biomolecular Engineering (BK21 Plus Program), Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141 Daejeon, Republic of Korea.
Sang Yup LeeMetabolic and Biomolecular Engineering National Research Laboratory, Korea Advanced Institute of Science and Technology, Yuseong-gu, 34141 Daejeon, Republic of Korea; leesy@kaist.ac.kr tjpark@cau.ac.kr.ORCID 0000-0003-0599-3091
Korea Advanced Institute of Science and Technology · KRChung-Ang University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanomaterials (NMs) are mostly synthesized by chemical and physical methods, but biological synthesis is also receiving great attention. However, the mechanisms for biological producibility of NMs, crystalline versus amorphous, are not yet understood. Here we report biosynthesis of 60 different NMs by employing a recombinant

Indexed as

NanostructuresBioreactorsEscherichia coliMetals, HeavyNanotechnologyOxidesMetals, HeavyOxidesbiosynthesisEscherichia colimulti-elementnanomaterialssingle element

Identifiers

PMID29784775
PMCPMC6003371
OpenAlexW2804629692

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.